B3GALT5 (NM_033172) Human Recombinant Protein
CAT#: TP313317
Purified recombinant protein of Homo sapiens UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 4
View other "B3GALT5" proteins (27)
Special Offer: Get a 20% discount on this product. Use code: "MVPro20".
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC213317. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 36 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_149362 |
Locus ID | 10317 |
UniProt ID | Q9Y2C3, A0A0A0MS93 |
Cytogenetics | 21q22.2 |
Refseq Size | 2711 |
Refseq ORF | 930 |
Synonyms | 3-GalTase 5; B3GalT-V; B3GalTx; B3T5; beta-1; beta-3-Gx-T5; beta3Gal-T5; GLCT5 |
Summary | This gene encodes a member of a family of membrane-bound glycoproteins. The encoded protein may synthesize type 1 Lewis antigens, which are elevated in gastrointestinal and pancreatic cancers. Alternatively spliced transcript variants using multiple alternate promoters have been observed for this gene. [provided by RefSeq, Sep 2017] |
Protein Families | Transmembrane |
Protein Pathways | Glycosphingolipid biosynthesis - globo series, Glycosphingolipid biosynthesis - lacto and neolacto series, Metabolic pathways |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC409690 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC409691 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC409692 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC409693 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC416890 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC429857 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC429858 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC429859 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC429860 | B3GALT5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY409690 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 |
USD 396.00 |
|
LY409691 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 3 |
USD 396.00 |
|
LY409692 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 4 |
USD 396.00 |
|
LY409693 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 5 |
USD 396.00 |
|
LY416890 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 1 |
USD 396.00 |
|
LY429857 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 |
USD 396.00 |
|
LY429858 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 3 |
USD 396.00 |
|
LY429859 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 4 |
USD 396.00 |
|
LY429860 | Transient overexpression lysate of UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 5 |
USD 396.00 |
|
PH311183 | B3GALT5 MS Standard C13 and N15-labeled recombinant protein (NP_149363) |
USD 2,055.00 |
|
PH313317 | B3GALT5 MS Standard C13 and N15-labeled recombinant protein (NP_149362) |
USD 2,055.00 |
|
PH314669 | B3GALT5 MS Standard C13 and N15-labeled recombinant protein (NP_149360) |
USD 2,055.00 |
|
PH314721 | B3GALT5 MS Standard C13 and N15-labeled recombinant protein (NP_149361) |
USD 2,055.00 |
|
PH315430 | B3GALT5 MS Standard C13 and N15-labeled recombinant protein (NP_006048) |
USD 2,055.00 |
|
TP311183 | Purified recombinant protein of Homo sapiens UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 5 |
USD 439.00 |
|
TP314669 | Purified recombinant protein of Homo sapiens UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 |
USD 748.00 |
|
TP314721 | Purified recombinant protein of Homo sapiens UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 3 |
USD 748.00 |
|
TP315430 | Recombinant protein of human UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 1 |
USD 748.00 |
{0} Product Review(s)
Be the first one to submit a review